Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors
Hélène Castel, Angéline Denouel, Marie Lange, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review
Rakshandha Saini, Nitin Sharma, Oluwole Solomon Oladeji, et al.
Journal of Ethnopharmacology (2021) Vol. 282, pp. 114570-114570
Closed Access | Times Cited: 129
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Jeanne S. Mandelblatt, Brent J. Small, George Luta, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3211-3222
Open Access | Times Cited: 153
Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors
Florence Joly, Marie Lange, Mélanie Dos Santos, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1896-1896
Open Access | Times Cited: 108
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
Afsana Sheikh, Shadab Md, Nabil A. Alhakamy, et al.
International Journal of Pharmaceutics (2022) Vol. 620, pp. 121751-121751
Closed Access | Times Cited: 51
Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors
Clémence Boscher, Florence Joly, Bénédicte Clarisse, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 3000-3000
Open Access | Times Cited: 63
How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment
Marie Lange, Florence Joly
Journal of Oncology Practice (2017) Vol. 13, Iss. 12, pp. 784-790
Closed Access | Times Cited: 62
Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer Patients
Florence Joly, Hélène Castel, Laure Tron, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 2, pp. 123-127
Open Access | Times Cited: 59
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Gwen Schroyen, Jeroen Blommaert, Donatienne Van Weehaeghe, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4198-4198
Open Access | Times Cited: 42
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment
Giulia Binarelli, Mylène Duivon, Florence Joly, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 3, pp. 249-268
Closed Access | Times Cited: 18
Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research
Gordon Winocur, Ian Johnston, Hélène Castel
Cancer Treatment Reviews (2018) Vol. 69, pp. 72-83
Closed Access | Times Cited: 47
Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities
Allison Magnuson, Tim A. Ahles, Bihong T. Chen, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 19, pp. 2138-2149
Open Access | Times Cited: 40
Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study
Mylène Duivon, François Christy, Emilie Thomas, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Hand grip strength and cognitive function among elderly cancer survivors
Lin Yang, Ai Koyanagi, Lee Smith, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0197909-e0197909
Open Access | Times Cited: 44
A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
Charlotte Kerstens, Hans Wildiers, Gwen Schroyen, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 12
An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI)
Laura Catalina Murillo, Jhon Jairo Sutachan, Sonia Luz Albarracín
Toxicology Reports (2023) Vol. 10, pp. 544-553
Open Access | Times Cited: 12
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Central Nervous System Plasticity Influences Language and Cognitive Recovery in Adult Glioma
Saritha Krishna, Sofia Kakaizada, Nyle Almeida, et al.
Neurosurgery (2020) Vol. 89, Iss. 4, pp. 539-548
Open Access | Times Cited: 27
Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature
Ali Amidi, Lisa M. Wu
Acta Oncologica (2019) Vol. 58, Iss. 5, pp. 522-536
Open Access | Times Cited: 26
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study
Andreas A. Argyriou, Sofia Karteri, Jordi Bruna, et al.
Supportive Care in Cancer (2021) Vol. 30, Iss. 2, pp. 1807-1814
Closed Access | Times Cited: 16
Impact of Cognitive Impairment in Patients with Gliomas
Deborah Allen, Ashlee R. Loughan
Seminars in Oncology Nursing (2018) Vol. 34, Iss. 5, pp. 528-546
Closed Access | Times Cited: 20
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer
Michelle C. Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.
Journal of Neuroimmunology (2021) Vol. 362, pp. 577769-577769
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top